Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 64, Issue 4, Pages 1331-1342
Publisher
Wiley
Online
2016-03-01
DOI
10.1002/hep.28527
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis
- (2015) P. A. Cortesi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection
- (2015) Benjamin P. Linas et al. ANNALS OF INTERNAL MEDICINE
- Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C Virus
- (2015) Mehdi Najafzadeh et al. ANNALS OF INTERNAL MEDICINE
- Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States
- (2015) Jagpreet Chhatwal et al. ANNALS OF INTERNAL MEDICINE
- Cost-effectiveness analysis of new drugs for chronic hepatitis C: The importance of updating utility values
- (2015) Paolo A. Cortesi et al. HEPATOLOGY
- Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus
- (2015) Nikolien van de Ven et al. HEPATOLOGY
- Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease
- (2015) Andrew J. Leidner et al. HEPATOLOGY
- Dynamic Simulation in Health Care Comes of Age
- (2015) Mark S. Roberts VALUE IN HEALTH
- Applying Dynamic Simulation Modeling Methods in Health Care Delivery Research—The SIMULATE Checklist: Report of the ISPOR Simulation Modeling Emerging Good Practices Task Force
- (2015) Deborah A. Marshall et al. VALUE IN HEALTH
- Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach
- (2015) Praveen Dhankhar et al. VALUE IN HEALTH
- Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection
- (2014) S. Saab et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Lamivudine Compared With Newer Antivirals for Prophylaxis of Hepatitis B Core Antibody Positive Livers: A Cost-Effectiveness Analysis
- (2014) A. J. Wright et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Sofosbuvir-Based Treatment Regimens for Chronic, Genotype 1 Hepatitis C Virus Infection in U.S. Incarcerated Populations
- (2014) Shan Liu et al. ANNALS OF INTERNAL MEDICINE
- Hepatitis C virus therapy in the direct acting antiviral era
- (2014) Mitchell L. Shiffman CURRENT OPINION IN GASTROENTEROLOGY
- Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C
- (2014) Ramón San Miguel et al. GUT
- The Influence of Cost-Effectiveness and Other Factors on Nice Decisions
- (2014) Helen Dakin et al. HEALTH ECONOMICS
- The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation
- (2014) Debbie Hartwell et al. HEALTH TECHNOLOGY ASSESSMENT
- Valuing cure: Bridging cost-effectiveness and coverage decisions for hepatitis C therapy
- (2014) Mai T. Pho et al. HEPATOLOGY
- Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
- (2014) Salvatore Petta et al. HEPATOLOGY
- Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C
- (2014) Emmanuel A. Tsochatzis et al. HEPATOLOGY
- Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals
- (2014) Liesl M. Hagan et al. HEPATOLOGY
- Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria
- (2014) Kheng Choon Lim et al. HEPATOLOGY
- Cost-effectiveness of upcoming treatments for hepatitis C: We need to get the models right
- (2014) Emmanuel A. Tsochatzis et al. JOURNAL OF HEPATOLOGY
- Cost-effectiveness of sofosbuvir in the treatment of patients with hepatitis C
- (2014) H. Leleu et al. JOURNAL OF VIRAL HEPATITIS
- Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options
- (2014) P. A. Cortesi et al. JOURNAL OF VIRAL HEPATITIS
- Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
- (2014) Roger Williams et al. LANCET
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapy for Hepatitis C — The Costs of Success
- (2014) Jay H. Hoofnagle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature
- (2014) Kevin Marsh et al. PHARMACOECONOMICS
- Cost-effectiveness of protease inhibitor based regimens for chronic hepatitis C: a systematic review of published literature
- (2014) Ramón San Miguel et al. Expert Review of Pharmacoeconomics & Outcomes Research
- New Protease Inhibitors for the Treatment of Chronic Hepatitis C
- (2013) Shan Liu et al. ANNALS OF INTERNAL MEDICINE
- Healthcare costs associated with hepatocellular carcinoma and the value of care
- (2013) Lorenzo G. Mantovani et al. HEPATOLOGY
- Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China
- (2013) Mehlika Toy et al. HEPATOLOGY
- Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma
- (2013) Alessandro Cucchetti et al. JOURNAL OF HEPATOLOGY
- Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients
- (2013) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- All-oral, interferon-free treatment for chronic hepatitis C: cost-effectiveness analyses
- (2013) L. M. Hagan et al. JOURNAL OF VIRAL HEPATITIS
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
- (2013) Don Husereau et al. VALUE IN HEALTH
- Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
- (2013) Natasha K Martin et al. BMJ Open
- Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population
- (2012) Alessandro Cucchetti et al. JOURNAL OF HEPATOLOGY
- Cost Effectiveness of Hepatitis C-Related Interventions Targeting Substance Users and Other High-Risk Groups
- (2012) Ava John-Baptiste et al. PHARMACOECONOMICS
- Cost Effectiveness of Screening Strategies for Early Identification of HIV and HCV Infection in Injection Drug Users
- (2012) Lauren E. Cipriano et al. PLoS One
- Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: Regional analyses according to the endemic context
- (2012) Ana Marli C. Sartori et al. VACCINE
- Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
- (2012) Andrew H. Briggs et al. VALUE IN HEALTH
- Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
- (2012) J. Jaime Caro et al. VALUE IN HEALTH
- Multiple Criteria Decision Analysis for Health Technology Assessment
- (2012) Praveen Thokala et al. VALUE IN HEALTH
- Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2
- (2012) Mark Roberts et al. VALUE IN HEALTH
- State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
- (2012) Uwe Siebert et al. VALUE IN HEALTH
- Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
- (2012) David M. Eddy et al. VALUE IN HEALTH
- Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test
- (2011) N. P. Polyzos et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations
- (2011) Natasha K. Martin et al. HEPATOLOGY
- Pricing and reimbursement of orphan drugs: the need for more transparency
- (2011) Steven Simoens Orphanet Journal of Rare Diseases
- Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: a systematic review
- (2010) Sekwon Jang et al. BREAST CANCER RESEARCH AND TREATMENT
- Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA
- (2010) Dana Goldman et al. HEALTH ECONOMICS
- Incorporating Equity–Efficiency Interactions in Cost-Effectiveness Analysis—Three Approaches Applied to Breast Cancer Control
- (2010) Stefan A. Baeten et al. VALUE IN HEALTH
- Public funding of new cancer drugs: Is NICE getting nastier?
- (2009) Anne R. Mason et al. EUROPEAN JOURNAL OF CANCER
- The cost-effectiveness of increasing kidney transplantation and home-based dialysis
- (2009) KIRSTEN HOWARD et al. NEPHROLOGY
- Key principles for the improved conduct of health technology assessments for resource allocation decisions
- (2008) Michael F. Drummond et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started